Eisai gets EMA nod for Lenvima just weeks after FDA approval

Eric Palmer

has gotten its second dose of good news in as many months. getting an FDA for its thyroid cancer drug , the struggling Japanese drugmaker has gotten the nod for the potential blockbuster by the European Medicines Agency (EMA).

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS